Clinical Trial Update: Phase 1 Study of GC1130A in Patients With Sanfilippo Syndrome Type A (MPS IIIA) [Phase 1]

View source ↗

Summary

Phase 1 study of GC1130A for Sanfilippo syndrome type A is currently recruiting, indicating early-stage investigation of the therapy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sanfilippo Syndrome Type

Drugs mentioned

• GC1130A

Snippet

Sponsor: GC Biopharma Corp | Conditions: Sanfilippo Syndrome Type A | Phase 1 | Status: RECRUITING